In metabolic disorders, PTX-3 has been reported to exert beneficial effects by influencing adipose tissue homeostasis [44], modulating macrophage polarization towards an anti-inflammatory (M2) phenotype [45], and reducing endothelial dysfunction [46]. The gene discussed is PTX3; the disease is Other metabolic disease.